clearinghouse to share best practices and foster innovation. This is a balance of thinking and doing, of establishing guidelines and experimenting with implementation.
The effort itself is also a product, and it must also create a trusted, authoritative, and self-sustaining international network that serves the public interest, to ultimately facilitate better heath. GA4GH must always be able to answer the question ''So what?'' and do so quickly and simply.
There are technical, regulatory, and ethical challenges inherent in sharing genomes. And so the practical work includes four working groups: Regulatory and Ethics, Data, Security, and Clinical.
Following a hallmark of agile software engineering as a model, these working groups are creating a working model using a process based on agency, consultation, and iteration to advance concepts to implementation rather quickly. These small working groups are very active (I can vouch for that-8 a.m. calls every week leading up to this meeting!). It is our task to write a charter, request comments, analyze the comments and make decisions about their impact, distribute initial work products in an open manner, get comments, and create a final work product. The steering committee signs off on process and content.
Because the individuals and organizations involved believe this will make a difference, they are committed to creating the infrastructure and governance to the achieve goals.
There are several generative tensions in the work. It is critical that the various working groups are focused on completing practical tasks and at the same time solving big challenges, resulting in a quest to balance engagement and action. There is also a tension between cooperation and competition. It is important to allow competition to provide incentives when it is generative but also to create incentives that foster cooperation. The significance of the diversity of genomes throughout the world is also critical to a truly global project.
When it was first mapped, the genome was much freer than many data sources in biomedical research. The cacophony of silo-building has been disturbing in the years since, and the GA4GH is gently, but hopefully, removing some of the walls so that data sharing can flourish. This is essential to human health and requires commitment and risk on the part of those who would most benefit from the silos. Many stakeholders have made the commitment and now are assessing the risks.
Genetic Alliance, Washington, District of Columbia. Pp. 375-376 DOI: 10.1089 /gtmb.2014 .1555 Let's boldly move forward in the name of those who need us the most.
GENETIC TESTING AND MOLECULAR BIOMARKERS
Volume 18, Number 6, 2014 ª Mary Ann Liebert, Inc.
